EUDA Health Holdings Limited (NasdaqCM:EUDA) signed a letter of intent to acquire TheoremRx Inc. on October 4, 2023. Under the letter of intent, TheoremRx would merge with a subsidiary of EUDA. The transaction is subject to the negotiation of a definitive agreement, regulatory approvals, and the satisfaction of customary closing conditions.